Date: 11/21/2024

Angela Kennedy, Senior Director, Nonprofit Organizations, IQVIA

Reid D’Amico, PhD, Principal, Regulatory Science & Study Innovation, U.S. Real World Solutions, IQVIA

The U.S. Food and Drug Administration (FDA) has increasingly emphasized the importance of real-world data and real-world evidence in regulatory decision-making, as highlighted in recent FDA Guidances. For patient organizations and research foundations, this evolution in the FDA’s perspective offers new opportunities to serve as the liaison between patients, the healthcare industry, and regulators – centered around patient data.

Read more here https://www.iqvia.com/locations/united-states/blogs/2024/10/patient-advocacy-organizations-as-influencers